Literature DB >> 9541914

MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data.

H Urbach1, J Klisch, H K Wolf, D Brechtelsbauer, S Gass, L Solymosi.   

Abstract

To ascertain whether increased grey matter signal intensity on T2-weighted images in patients with sporadic Creutzfeldt-Jakob disease (CJD) corresponds to the stage and severity of this disease, we correlated MRI findings in four of our own and previously reported patients with sporadic CJD with the clinical variants, neuropathological changes at autopsy, duration of the disease and survival time after MRI examination. Of 15 patients with the extrapyramidal type of CJD, 10 showed increased signal in the basal ganglia on T2-weighted images. One of seven patients with the Heidenhain variant had increased signal in the occipital cortex. Patients without increased grey matter signal intensity had a longer overall duration of CJD (P = 0.035). Although the interval between onset of neurological symptoms and MRI was not different, patients without increased grey matter signal also survived longer after MRI examination (P = 0.022).

Entities:  

Mesh:

Year:  1998        PMID: 9541914     DOI: 10.1007/s002340050542

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  21 in total

1.  Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging.

Authors:  Heike Russmann; Francois Vingerhoets; Judith Miklossy; Philippe Maeder; Markus Glatzel; Adriano Aguzzi; Julien Bogousslavsky
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

2.  Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease.

Authors:  H J Tschampa; K Kallenberg; H A Kretzschmar; B Meissner; M Knauth; H Urbach; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

3.  Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease.

Authors:  Michael D Geschwind; Christopher A Potter; Mamta Sattavat; Paul A Garcia; Howard J Rosen; Bruce L Miller; Stephen J DeArmond
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

4.  Creutzfeldt-Jakob disease: case discussion and imaging review.

Authors:  Cory Morgan; Manu Gupta; Waleed El-Feky; Sadat Shamim; Michael Opatowsky
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-01

5.  Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.

Authors:  E-J Kim; S-S Cho; B-H Jeong; Y-S Kim; S W Seo; D L Na; M D Geschwind; Y Jeong
Journal:  Eur J Neurol       Date:  2011-11-04       Impact factor: 6.089

6.  Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis.

Authors:  Geoffrey S Young; Michael D Geschwind; Nancy J Fischbein; Jennifer L Martindale; Roland G Henry; Songling Liu; Ying Lu; Stephen Wong; Hong Liu; Bruce L Miller; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

7.  Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging.

Authors:  Takaki Murata; Yusei Shiga; Shuichi Higano; Shoki Takahashi; Shunji Mugikura
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

8.  Relationship between clinical course and Diffusion-weighted MRI findings in sporadic Creutzfeldt-Jakob Disease.

Authors:  Sang-Hun Yi; Key-Chung Park; Sung-Sang Yoon; Eui-Jong Kim; Won-Chul Shin
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

9.  Clinical radiological correlation in E200K familial Creutzfeldt-Jakob disease.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Oliver L Siaw; Naama Warman-Alaluf; Zeev Nitsan; Shmuel Appel; Esther Kahana; Hanna Rosenmann; Chen Hoffmann
Journal:  J Neural Transm (Vienna)       Date:  2016-09-13       Impact factor: 3.575

10.  Heidenhain variant of Creutzfeldt-Jakob disease: An autopsy study from India.

Authors:  Monica Kher; Medha Y Rao; P T Acharya; Anita Mahadevan; S K Shankar
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.